TY - JOUR T1 - Resolution of the recent performance problem of Abbott LCx <em>Chlamydia trachomatis</em> assay. Issues of repeat testing for confirmation of chlamydial infection JF - Sexually Transmitted Infections JO - Sex Transm Infect SP - 225 LP - 226 DO - 10.1136/sti.78.3.225-a VL - 78 IS - 3 AU - H Mallinson AU - J Hopwood AU - K Mutton Y1 - 2002/06/01 UR - http://sti.bmj.com/content/78/3/225.2.abstract N2 - In February 2001, Abbott Laboratories issued a device correction notice to users of their LCx Chlamydia trachomatis assay suggesting that initially reactive ligase chain reaction (LCR) tests should be repeated on the same sample to validate the test result. A recent alert (December 2001) from the Medical Devices Agency (MDA, DA2001(09)) indicates that the device correction is still in force and points out the resource implications where retesting is required. We offer some data on LCR performance characteristics during this period and before.The Department of Health pilot study on “Opportunistic screening for genital chlamydial infection in Portsmouth and Wirral” ran for a year up to October 2000. … ER -